Dr. Khoury was awarded the Georgia Cancer Coalition Distinguished Cancer Scholarship which permitted the establishment of the Hematological Disorders Tissue Bank at Emory University.
Titles and Roles
- Director, Division of Hematology
- Winship Cancer Institute of Emory University
- Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Research Program
- Discovery and Developmental Therapeutics
A recipient of the R. Randall Rollins Chair in Oncology, Dr. Khoury is an established authority in hematological malignancies, particularly leukemia and myelodysplastic syndromes. He leads the division of hematology at Winship Cancer Institute which treated over 1,900 patients, both malignant and benign cases, in 2013.
Dr. Khoury earned his Medical Degree from the Université Catholique de Louvain in Brussels, Belgium, and then completed his residency in internal medicine at Memorial Medical Center in Savannah, Georgia, and his fellowship in hematology and medical oncology at Washington University in St. Louis, Missouri.
Dr. Khoury’s research interests focus on development of new drugs in leukemia and myelodysplasia, and in the identification of genetic markers that predict outcomes in patients with hematological cancers. This data will be used to help physicians individualize therapies including a bone marrow transplant if necessary to prevent relapse following standard chemotherapy.
He has conducted several leukemia and bone marrow transplant clinical trials, including pivotal trials that have led to the approval of drugs such as bosutinib, dasatinib, ponatinib and omacetaxine.
Using a specialized software he designed and developed, Dr. Khoury instituted models of cost-effective care across the inpatient and outpatient services at Emory Healthcare. These models are in line with future healthcare reforms currently planned and will likely serve as benchmarks in this field.
In collaboration with the Center for International Bone Marrow Transplant Research, Dr. Khoury conducted clinical trials investigating impact of specific drugs on outcomes of allogeneic stem cell transplantation.
Dr. Khoury's research efforts focus on the development of translational trials in leukemia and bone marrow transplantation, and are reflected in over 100 peer-reviewed papers, of which he is first or senior author.